Home » Sonomax conference call update additional agenda item

Press Releases

Sonomax conference call update additional agenda item

 

Montreal, Quebec, February 2nd , 2009 / CNW Telbec / Sonomax Hearing Healthcare Inc.
(SHH:TSX Venture) announces that with reference to its previously-announced conference call
scheduled for February 4th, 2010 at 11:00 AM EST, in addition to updating investors on the
results of Sonomax’s initiative to license its new Self-Fit™ headset technology at the recent
Consumer Electronics Show in Las Vegas, and the company’s outlook for 2010 and beyond, the
company will also report on the $1.74 million non-dilutive financing arrangement that it has
entered into with Benvest New Look Income Fund (BCI:UN: TSX).
All interested parties are invited to participate by dialling toll-free 1-866-365-1119 (North
America only) and 1-416-849-7329 Outside North America. You will be put on hold until the
conference call begins.
Management’s report will be followed by a Question and Answer period. Management notes
that Sonomax is bound by a number of Non-Disclosure Agreements that were entered into at or
before the CES, and that consequently, some of the information that is communicated will need
to remain generic. We trust investors will understand the sensitive nature of our licensing
business model.
A PowerPoint Presentation will be available for download on Thursday February 4th at 9:00AM
EST in the Investor Relations section of the Sonomax website http://sonomax.com/investorrelations/
investing-in-sonomax.html. A copy of live Web cast will be available following the
conference call in the same section.
Sonomax also announces that its detailed management proxy circular describing the proposed
arrangement with Benvest New Look Income Fund is being mailed to Sonomax shareholders
and holders of Sonomax’s convertible promissory notes. The management proxy circular is
available on SEDAR at www.sedar.com and will also be available on Sonomax’s website at
www.sonomax.com.
About the New Sonomax
Sonomax is a leader in the research, development and licensing of in-ear technologies. With
over 50 patents worldwide, Sonomax pioneering innovation includes instant custom-fitting
earpieces that deliver the most comfortable, protective and sound-enhancing experience in the
world, as well as software driven solutions for validating earpiece performance. The latest V4
Self-Fit™ System offers our manufacturer and aftermarket clients a broader range of
opportunities in customized earpieces for personal entertainment, mobile communication and
Bluetooth™ headsets. The technology also extends to applications for self-fit earplugs for
hearing protection and communication in the industrial and military market sectors.
This news release contains certain forward-looking statements that reflect the current views and/or expectations of
Sonomax Hearing Healthcare Inc. with respect to its performance, business and future events. Such statements are
subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly. In
particular, no assurance can be given as to whether a proposed plan of arrangement and $1.74 million non-dilutive
fina
ncin
g with Benvest New Look Income Fund will be completed.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of
the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For Further Information:
Nick Laperle, President & CEO
Tel: 514-932-2674 ext 2229
Email: nlaperle@sonomax.com, Web: sonomax.com

Montreal, Quebec, February 2nd , 2009 / CNW Telbec / Sonomax Hearing Healthcare Inc. (SHH:TSX Venture) announces that with reference to its previously-announced conference call scheduled for February 4th, 2010 at 11:00 AM EST, in addition to updating investors on the results of Sonomax’s initiative to license its new Self-Fit™ headset technology at the recent Consumer Electronics Show in Las Vegas, and the company’s outlook for 2010 and beyond, the company will also report on the $1.74 million non-dilutive financing arrangement that it has entered into with Benvest New Look Income Fund (BCI:UN: TSX).

All interested parties are invited to participate by dialling toll-free 1-866-365-1119 (North America only) and 1-416-849-7329 Outside North America. You will be put on hold until the conference call begins.

Management’s report will be followed by a Question and Answer period. Management notes that Sonomax is bound by a number of Non-Disclosure Agreements that were entered into at or before the CES, and that consequently, some of the information that is communicated will need to remain generic. We trust investors will understand the sensitive nature of our licensing business model.

A PowerPoint Presentation will be available for download on Thursday February 4th at 9:00AM EST in the Investor Relations section of the Sonomax website http://sonomax.com/investorrelations investing-in-sonomax.html. A copy of live Web cast will be available following the conference call in the same section.

Sonomax also announces that its detailed management proxy circular describing the proposed arrangement with Benvest New Look Income Fund is being mailed to Sonomax shareholders and holders of Sonomax’s convertible promissory notes. The management proxy circular is available on SEDAR at www.sedar.com and will also be available on Sonomax’s website at www.sonomax.com.

About the New Sonomax

Sonomax is a leader in the research, development and licensing of in-ear technologies. With over 50 patents worldwide, Sonomax pioneering innovation includes instant custom-fitting earpieces that deliver the most comfortable, protective and sound-enhancing experience in the world, as well as software driven solutions for validating earpiece performance. The latest V4 Self-Fit™ System offers our manufacturer and aftermarket clients a broader range of opportunities in customized earpieces for personal entertainment, mobile communication and Bluetooth™ headsets. The technology also extends to applications for self-fit earplugs for hearing protection and communication in the industrial and military market sectors.

This news release contains certain forward-looking statements that reflect the current views and/or expectations of Sonomax Hearing Healthcare Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly. In particular, no assurance can be given as to whether a proposed plan of arrangement and $1.74 million non-dilutive fina ncin g with Benvest New Look Income Fund will be completed.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For Further Information:

Nick Laperle, President & CEO

Tel: 514-932-2674 ext 2229

Email: nlaperle@sonomax.com, Web: sonomax.com